EPISODE · Sep 12, 2024 · 50 MIN
Sept. 12, 2024: What’s next for MDMA after FDA rejection? Interpreting a lost Euripidean find
from Colorado Matters
Researchers hoped the FDA would approve the drug commonly known as "ecstasy" to help treat PTSD. But now that the FDA has rejected it in a surprise decision, what's next for the psychedelic? Then, two CU Boulder scholars interpret what they believe to be previously unknown fragments of two lost tragedies by the Greek playwright Euripides. And, using mammograms to increase awareness of dense breast tissue.
NOW PLAYING
Sept. 12, 2024: What’s next for MDMA after FDA rejection? Interpreting a lost Euripidean find
No transcript for this episode yet
Similar Episodes
Jun 20, 2026 ·31m
Jun 20, 2026 ·24m
Jun 20, 2026 ·42m
Jun 20, 2026 ·26m
Jun 20, 2026 ·22m
Jun 20, 2026 ·37m